J A Chris Delaney
Overview
Explore the profile of J A Chris Delaney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cadarette S, MacLure M, Delaney J, Whitaker H, Hayes K, Wang S, et al.
Pharmacoepidemiol Drug Saf
. 2021 Mar;
30(6):671-684.
PMID: 33715267
Purpose: Consensus is needed on conceptual foundations, terminology and relationships among the various self-controlled "trigger" study designs that control for time-invariant confounding factors and target the association between transient exposures...
2.
Feinstein M, Nance R, Delaney J, Heckbert S, Budoff M, Drozd D, et al.
BMC Med
. 2019 Aug;
17(1):149.
PMID: 31362721
Background: Persons with human immunodeficiency virus (HIV) have higher risks for myocardial infarction (MI) than the general population. This is driven in part by higher type 2 MI (T2MI, due...
3.
Kim H, Nance R, Williams-Nguyen J, Delaney J, Crane H, Cachay E, et al.
Open Forum Infect Dis
. 2019 Apr;
6(4):ofz100.
PMID: 30949539
Background: Direct-acting antiviral (DAA) therapy have been shown to be highly successful in clinical trials and observational studies, but less is known about treatment success in patients with a high...
4.
Nance R, Delaney J, Simoni J, Wilson I, Mayer K, Whitney B, et al.
Ann Intern Med
. 2018 Aug;
169(6):376-384.
PMID: 30140916
Background: Because HIV viral suppression is essential for optimal outcomes and prevention efforts, understanding trends and predictors is imperative to inform public health policy. Objective: To evaluate viral suppression trends...
5.
Chandler R, Gordon M, Kruszka B, Strand L, Altice F, Beckwith C, et al.
Subst Abuse Treat Prev Policy
. 2017 May;
12(1):24.
PMID: 28511680
Background: The STTR treatment cascade provides a framework for research aimed at improving the delivery of services, care and outcomes of PLWH. The development of effective approaches to increase HIV...
6.
Crane H, Paramsothy P, Drozd D, Nance R, Delaney J, Heckbert S, et al.
JAMA Cardiol
. 2017 Jan;
2(3):260-267.
PMID: 28052152
Importance: The Second Universal Definition of Myocardial Infarction (MI) divides MIs into different types. Type 1 MIs result spontaneously from instability of atherosclerotic plaque, whereas type 2 MIs occur in...
7.
Nance R, Delaney J, Golin C, Wechsberg W, Cunningham C, Altice F, et al.
AIDS Care
. 2016 Dec;
29(4):464-468.
PMID: 27910703
Adherence to antiretroviral therapy (ART) is an important determinant of clinical success assessed in many HIV studies. Harmonizing adherence data from studies that use different measures is difficult without a...
8.
Reina S, Llabre M, Allison M, Wilkins J, Mendez A, Arnan M, et al.
Atherosclerosis
. 2015 Oct;
243(1):314-9.
PMID: 26425994
Background And Purpose: Accurate identification of risk factors for stroke is important for public health promotion and disease prevention. HDL cholesterol is a potential risk factor, yet its role in...
9.
Duran L, Rodriguez C, Drozd D, Nance R, Delaney J, Burkholder G, et al.
AIDS Res Treat
. 2015 Aug;
2015:478750.
PMID: 26273478
Fructosamine is an alternative method to hemoglobin A1c (HbA1c) for determining average glycemia. However, its use has not been extensively evaluated in persons living with HIV (PLWH). We examined the...
10.
Swerdlow D, Holmes M, Kuchenbaecker K, Engmann J, Shah T, Sofat R, et al.
Lancet
. 2012 Mar;
379(9822):1214-24.
PMID: 22421340
Background: A high circulating concentration of interleukin 6 is associated with increased risk of coronary heart disease. Blockade of the interleukin-6 receptor (IL6R) with a monoclonal antibody (tocilizumab) licensed for...